A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis
NCT06118619 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2023-11-09
Summary
The main purpose of testing: To confirm the effectiveness and safety of the drug Ingaron when used in patients hospitalized at the research center for various reasons.
Conditions
- Respiratory Tuberculosis
Interventions
- DRUG
-
Interferon-Gamma
received by microbiological synthesis; specific antiviral activity on cells is 2x10\*7 Units per mg of protein
Sponsors & Collaborators
-
SPP Pharmaclon Ltd.
lead INDUSTRY
Principal Investigators
-
Anatoly I Saulin, Master · SPP Pharmaclon Ltd.
Eligibility
- Min Age
- 18 Years
- Max Age
- 78 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-01
- Primary Completion
- 2023-12-31
- Completion
- 2024-03-01
Countries
- Russia
Study Locations
More Related Trials
-
Test to Treat TB: Impact of Sputum Sequencing-guided Individualised Therapy on Outcomes in Drug-resistant Tuberculosis
NCT05007795 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prognostic Value of Interferon Gamma Release Assays in Predicting Active Tuberculosis Among Individuals With, or at Risk of, Latent Tuberculosis Infection
NCT01162265 ·Status: COMPLETED
-
Interferon-gamma as Adjunctive Therapy in Chronic Pulmonary Aspergillosis: a Randomised Feasibility Study
NCT05653193 ·Status: RECRUITING ·Phase: PHASE2
-
Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients
NCT01608685 ·Status: COMPLETED
-
Safety, Tolerability, Extended Early Bactericidal Activity and PK of Higher Doses Rifampicin in Adults With Pulmonary TB
NCT01392911 ·Status: COMPLETED ·Phase: PHASE2
-
New Generation IGRA in Immunocompromised Individuals
NCT02639936 ·Status: COMPLETED
-
Clinical Evaluation of an IGRA Test for the Diagnosis of Active and Latent Tuberculosis
NCT06485895 ·Status: RECRUITING ·Phase: NA
-
Trial of High-Dose Rifampin in Patients With TB
NCT01408914 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Intravenous Treatment of Tuberculosis
NCT04150367 ·Status: TERMINATED
-
Rifampicin at High Dose for Difficult-to-Treat Tuberculosis
NCT04768231 ·Status: UNKNOWN ·Phase: PHASE2
-
The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection
NCT01685905 ·Status: UNKNOWN
-
Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
NCT02901288 ·Status: UNKNOWN ·Phase: PHASE4
-
Prevention of Secondary Infections by Interferon Gamma in ICU-acquired Sustained Immune-suppression
NCT06774235 ·Status: RECRUITING ·Phase: PHASE3
-
Innovation in Tuberculosis
NCT04002869 ·Status: UNKNOWN
-
The Correlate of Risk Targeted Intervention Study
NCT02735590 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)
NCT05081401 ·Status: RECRUITING ·Phase: PHASE3
-
Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
NCT01622140 ·Status: COMPLETED
-
Evaluation of the QuantiFERON-TB Test.
NCT02142894 ·Status: COMPLETED
-
Tuberculosis (TB) Immunotherapy Phase 2 Study
NCT01380119 ·Status: COMPLETED ·Phase: PHASE2
-
Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
NCT05021731 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Performance Evaluation of the VIDAS TB-IGRA Assay.
NCT04048018 ·Status: COMPLETED
-
Detection of Latent Tuberculosis in Hemodialysis Patients
NCT00695734 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics of High Versus Standard Dose Rifampicin in Patients With Pulmonary Tuberculosis
NCT00760149 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Study of the ТВ/Flu-05Е Tuberculosis Vaccine
NCT06873282 ·Status: COMPLETED ·Phase: PHASE2
-
The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB
NCT02409290 ·Status: COMPLETED ·Phase: PHASE3